Oculeve
AcquiredSan Francisco, United States · Founded 2011
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2011
- Business Model
- B2B
- Last Round
- Series BMar 2014
- Rounds
- 3
- Acquired by
- AllerganJul 2015
About
Oculeve was a medical device company that developed TrueTear, a first-in-class non-invasive nasal neurostimulation device that activates the nasolacrimal pathway to stimulate natural tear production in patients with dry eye disease. Founded out of Stanford Biodesign, the company raised $24M before being acquired by Allergan in 2015 for $125 million upfront. The TrueTear device received FDA clearance and commercialized under Allergan.
Summary
Oculeve is a Biotech company based in San Francisco, United States, founded in 2011. Its most recent funding was a Series B round in Mar 2014. Investors include Kleiner Perkins, Allergan and New Enterprise Associates.
Funding History
Jul 2015
Sign up to see all 4 rounds
Seed through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oculeve"><img src="https://indexed.vc/api/badge/company/oculeve" alt="Oculeve on Indexed.vc" width="260" height="76" /></a>